The primary objective evaluated COPD interventions in a pharmacist-led telemedicine clinic. Secondary objectives quantified emergency department (ED) visits and hospitalizations for COPD exacerbations.

A single-center, outpatient telemedicine clinic within the Veterans Affairs (VA) Tennessee Valley Healthcare System from January 2021 through June 2021.

Patients with an active COPD diagnosis and assigned to a primary care team within the local VA were reviewed for enrollment. Visits were conducted through VA video connect (VVC) or telephone. During these appointments, pertinent information was collected and pharmacotherapy and nonpharmacotherapy interventions were implemented to optimize COPD management.

Visits were conducted by a postgraduate year two ambulatory care pharmacy resident under supervision of a clinical pharmacy specialist with a scope of practice. Appointments were virtual to reduce COVID-19 exposure and increase access to care. Patients were identified through a COPD patient report and provider referral to target high risk patients.

Interventions made were documented at each visit. Chart review and patient interview were utilized to quantify ED visits or hospitalizations for COPD exacerbations occurring the year prior to or during clinic enrollment.

Of 82 charts reviewed, 18 patients were eligible for enrollment. Eleven were followed as seven patients did not show for initial visits. A total of 31 COPD interventions occurred including 13 nonpharmacotherapy (i.e. inhaler education, smoking cessation) and 18 pharmacotherapy (i.e. optimization of COPD regimens). An average of 3 COPD interventions were completed per patient followed. No ED visits and two hospitalizations for a COPD exacerbation occurred during the study period. This cohort had one ED visit and 10 hospitalizations the year prior to enrollment.

This telemedicine clinic experience, albeit a small study population, suggests an opportunity for pharmacists to provide pharmacotherapy and nonpharmacotherapy interventions which may improve COPD-related outcomes and access to care.